2016
DOI: 10.1080/17425255.2016.1196186
|View full text |Cite
|
Sign up to set email alerts
|

Nano-based strategies to overcome p-glycoprotein-mediated drug resistance

Abstract: Overcoming cancer drug resistance using innovative nanotechnology is being increasingly used and developed. Among resistance mechanisms, drug efflux transporter inhibitors and MDR gene expression silencing are among the those being investigated. In the near future, it seems some of these nanomedical approaches might become the mainstay of effective treatment of important human conditions like cancer.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
30
0

Year Published

2017
2017
2019
2019

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 42 publications
(30 citation statements)
references
References 116 publications
0
30
0
Order By: Relevance
“…Beyond chemical modification of a drug, advances in other technologies are also looking promising. For example nanoparticle delivery systems to allow better targeting or addressing specific molecular alterations in resistant tumours [73]. It may also be possible to develop multifunctional nanoparticles able to simultaneously target multiple resistance mechanisms.…”
Section: Use Of Multiple Mechanismsmentioning
confidence: 99%
“…Beyond chemical modification of a drug, advances in other technologies are also looking promising. For example nanoparticle delivery systems to allow better targeting or addressing specific molecular alterations in resistant tumours [73]. It may also be possible to develop multifunctional nanoparticles able to simultaneously target multiple resistance mechanisms.…”
Section: Use Of Multiple Mechanismsmentioning
confidence: 99%
“…Pglycoprotein (P-gp) membrane proteins are encoded by MDR gene family; which is well known as ABC transporters (153). P-gp effluxes hydrophobic and positively charged xenobiotics like DOX and paclitaxel out of the cells; and reduce the chemotherapy efficiency (154)(155)(156). D188 (Aspartic acid in the position 188), E353 (Glutamic acid in the position 353), E782, and D997 are residues close to the membrane surface and are located outside the perimeter of the intracellular domain helices of P-gp inside the chamber.…”
Section: Importance Of Zp In Overcoming Multidrug Resistance In Cancementioning
confidence: 99%
“…In the efforts to combat MDR, nanoparticles (NPs) composed of gold, silver, or titanium dioxide (TiO 2 ) are thought to be one of the most promising strategies, as they can accumulate specifically and rapidly in cancer cells by enhanced permeability and retention effects (Niazi et al, ; Yin, Deng, Zhang, & Lin, ). More importantly, nano‐sized medicines enter cancer cells by endocytic pathways, therefore circumventing the efflux of transporters (Li et al, ).…”
Section: Introductionmentioning
confidence: 99%